Free Trial

National Health Investors (NHI) Stock Forecast & Price Target

National Health Investors logo
$76.65
-1.80 (-2.29%)
(As of 10/31/2024 ET)

National Health Investors - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
4

Based on 7 Wall Street analysts who have issued ratings for National Health Investors in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 3 have given a hold rating, and 4 have given a buy rating for NHI.

Consensus Price Target

$73.29
-4.39% Downside
According to the 7 analysts' twelve-month price targets for National Health Investors, the average price target is $73.29. The highest price target for NHI is $92.00, while the lowest price target for NHI is $55.00. The average price target represents a forecasted downside of -4.39% from the current price of $76.65.
Get the Latest News and Ratings for NHI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for National Health Investors and its competitors.

Sign Up

NHI Analyst Ratings Over Time

TypeCurrent Forecast
11/1/23 to 10/31/24
1 Month Ago
10/2/23 to 10/1/24
3 Months Ago
8/3/23 to 8/2/24
1 Year Ago
11/1/22 to 11/1/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$73.29$73.29$62.13$53.17
Forecasted Upside-4.39% Downside-11.79% Downside-16.39% Downside5.85% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

NHI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NHI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

National Health Investors Stock vs. The Competition

TypeNational Health InvestorsFinance CompaniesS&P 500
Consensus Rating Score
2.57
2.48
2.50
Consensus RatingModerate BuyHoldHold
Predicted Upside-4.26% Downside13.94% Upside9.72% Upside
News Sentiment Rating
Neutral News

See Recent NHI News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/1/2024Wells Fargo & Company
3 of 5 stars
J. Feldman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$81.00 ➝ $86.00+2.32%
9/24/2024Bank of America
4 of 5 stars
 Initiated CoverageBuy$92.00+8.50%
8/30/2024Truist Financial
2 of 5 stars
 Boost TargetHold ➝ Hold$65.00 ➝ $78.00-3.49%
3/18/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$64.00 ➝ $66.00+9.33%
3/12/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$67.00+13.53%
1/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$69.00+27.38%
11/28/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Hold$55.00+1.08%
9/28/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$54.00+6.08%
9/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$52.00+2.87%
3/29/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$55.00 ➝ $50.00+0.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:21 PM ET.


NHI Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for National Health Investors is $73.29, with a high forecast of $92.00 and a low forecast of $55.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NHI shares.

According to analysts, National Health Investors's stock has a predicted downside of -4.39% based on their 12-month stock forecasts.

Over the previous 90 days, National Health Investors's stock had 1 downgrade by analysts.

National Health Investors has been rated by research analysts at Bank of America, Truist Financial, and Wells Fargo & Company in the past 90 days.

Analysts like National Health Investors more than other "finance" companies. The consensus rating for National Health Investors is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how NHI compares to other companies.


This page (NYSE:NHI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners